Two university researchers say they’re optimistic that their work will have long-term benefits. But the sometimes-vitriolic response they receive can be deeply frustrating.
At one time the authorities considered an oral-history project to be key evidence in solving a murder. On Tuesday they described the records as mere "hearsay."
In a report delivered to Congress on Tuesday, the National Academy of Sciences also argued for an independent oversight board that would be financed by universities but granted government authority.
How could a 2001 study of the drug Paxil get the facts so wrong? A team of volunteer researchers spent two years trying to find out.
On average, male biomedical researchers received start-up packages nearly two-and-a-half times larger than those awarded to female scholars.
When research projects broadcast candidates’ party affiliation in nonpartisan campaigns or ask drivers to break traffic laws, are they stepping over the line?
A 519-page set of regulations from the U.S. Department of Health and Human Services would relax the approvals process for research that involves human subjects but puts them at little or no risk.
A study attempts to draw links between life expectancy, approvals of new drugs, and research supported by the NIH. Some experts say those aren’t dots that can be connected.
Yoni Freedhoff has long been a fierce advocate on health and nutrition. Now he has helped to expose what many scientists see as a serious conflict of interest.
Paul S. Aisen’s decision to move his Alzheimer’s-research program from one California university to another led to a nasty dispute.
Supporters of the new policy say it's needed to restore trust in the group, which a recent report criticized as colluding with the Pentagon to soften its ethics guidelines.
The government now requires many scientists to announce what they intend to test. A new study says that has made it harder for some of them to claim positive findings.
The new applied-science campus in Manhattan hopes to channel the bold start-up ethos of its partner, the Technion-Israel Institute of Technology.
When Paul S. Aisen left one California university for another, he planned to take a $55-million grant along with him. Not so fast, said his old employer.